Table 2.
Comparison of post-transplant complications between post-transplant dyslipidemia and non-post-transplant dyslipidemia groups
| PTDL (n = 278) | Non-PTDL (n = 118) | P value | |
| Acute kidney injury | 69 (24.8) | 27 (22.9) | 0.681 |
| Early allograft dysfunction | 84 (30.2) | 37 (31.4) | 0.822 |
| Portal vein stenosis | 5 (1.8) | 2 (1.7) | 0.943 |
| CMV infection | 4 (1.4) | 3 (2.5) | 0.730 |
| Bacterial infection | 28 (10.1) | 7 (5.9) | 0.184 |
| Diabetes mellitus | 21 (7.6) | 5 (4.2) | 0.233 |
| Hypertension | 13 (4.7) | 7 (5.9) | 0.602 |
| Cardiovascular diseases | 7 (2.5) | 1 (0.8) | 0.490 |
| Chronic kidney failure | 3 (1.1) | 0 (0) | 0.681 |
| Biliary complications | 40 (14.4) | 15 (12.7) | 0.659 |
| HCC recurrence1 | 60 (55.5) | 21 (34.4) | 0.008 |
1
In 169 HCC patients. PTDL: Post-transplant dyslipidemia; CMV: Cytomegalovirus; HCC: Hepatocellular carcinoma.